Literature DB >> 7589128

Normal clonal expansion but impaired Fas-mediated cell death and anergy induction in interleukin-2-deficient mice.

B Kneitz1, T Herrmann, S Yonehara, A Schimpl.   

Abstract

Despite a normal development of all major lymphoid subsets, with time, interleukin-2 (IL-2)-deficient mice develop a fatal immunopathology. The disease phenotype is characterized by lymphoadenopathy, splenomegaly, T cell infiltration of various organs, overproduction of a number of cytokines and autoantibody formation. Phenotypically, CD4+ and CD8+ T cells exhibit features characteristic of antigenically experienced cells. The accumulation of cells with a memory phenotype together with the previous suggestion of an involvement of IL-2 in the termination phase of immune responses prompted us to study the fate of superantigen-reactive T cells in IL-2-deficient mice in comparison to their IL-2-producing littermates. We show that expansion in vivo of CD4+ and, to a lesser extent, CD8+ T cells reactive to the superantigens staphylococcal enterotoxin A and B (SEA and SEB) proceeds normally in the absence of IL-2, but that fewer CD4+ cells are subsequently deleted. The residual superantigen-reactive cells fail to become anergic as measured by proliferation in vitro in response to the same superantigen. T cell blasts generated in vitro from lymph node cells of IL-2-deficient mice by superantigen stimulation in the absence of exogenous IL-2 also fail to become anergic. In contrast to cells from IL-2-producing littermates, they do not exhibit Fas-induced apoptosis when cultured on anti-Fas antibody-coated plates, although Fas expression by IL-2-deficient cells is normal or even elevated compared to the IL-2-producing control cells. The data suggest that activation of T cells in the absence of IL-2 fails to generate a signal which is necessary to activate the apoptotic pathway and thus leads to an accumulation of antigen-experienced cells and the chronic inflammatory responses observed in IL-2-deficient mice.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7589128     DOI: 10.1002/eji.1830250925

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  32 in total

1.  In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro.

Authors:  Ludger Klein; Khashayarsha Khazaie; Harald von Boehmer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-11       Impact factor: 11.205

Review 2.  Homeostatic T cell proliferation as a barrier to T cell tolerance.

Authors:  Somia P Hickman; Laurence A Turka
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

3.  Impaired B cell responses to orally administered antigens in lamina propria but not Peyer's patches of Galphai2-deficient mice prior to colitis.

Authors:  Lena Ohman; Rolf-Göran Aström; Elisabeth Hultgren Hörnquist
Journal:  Immunology       Date:  2005-06       Impact factor: 7.397

4.  Gamma chain receptor interleukins: evidence for positive selection driving the evolution of cell-to-cell communicators in the mammalian immune system.

Authors:  Mary J O'Connell; James O McInerney
Journal:  J Mol Evol       Date:  2005-10-04       Impact factor: 2.395

Review 5.  The future of interleukin-2: enhancing therapeutic anticancer vaccines.

Authors:  W W Overwijk; M R Theoret; N P Restifo
Journal:  Cancer J Sci Am       Date:  2000-02

6.  Disrupted B-lymphocyte development and survival in interleukin-2-deficient mice.

Authors:  M Schultz; S H Clarke; L W Arnold; R B Sartor; S L Tonkonogy
Journal:  Immunology       Date:  2001-10       Impact factor: 7.397

7.  Functional dissection of the cytoplasmic subregions of the IL-2 receptor betac chain in primary lymphocyte populations.

Authors:  H Fujii; K Ogasawara; H Otsuka; M Suzuki; K Yamamura; T Yokochi; T Miyazaki; H Suzuki; T W Mak; S Taki; T Taniguchi
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

8.  Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression.

Authors:  P K Epling-Burnette; J H Liu; R Catlett-Falcone; J Turkson; M Oshiro; R Kothapalli; Y Li; J M Wang; H F Yang-Yen; J Karras; R Jove; T P Loughran
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

9.  Manipulating IL-2 availability amid presentation of donor MHC antigens suppresses murine alloimmune responses by inducing regulatory T cells.

Authors:  Shuzi Zhang; Hehua Dai; Ni Wan; Yolonda Moore; Zhenhua Dai
Journal:  PLoS One       Date:  2010-01-18       Impact factor: 3.240

10.  CD4+ T cell-derived IL-2 signals during early priming advances primary CD8+ T cell responses.

Authors:  Yo-Ping Lai; Chia-Ching Lin; Wan-Jung Liao; Chih-Yung Tang; Shu-Ching Chen
Journal:  PLoS One       Date:  2009-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.